The way things are looking now, 1B seems too high. Like you said, in breast cancer Abraxane looks more similar than different than paclitaxel and I think it will not be a commercial success in lung cancer either. Pancreatic and melanoma are a coin toss...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.